27P - Single-nucleotide polymorphism variation (SNV): Possible candidates as predictive biomarkers to response and progression free survival (PFS) in cutaneous malignant melanoma (CMM) patients treated with immune checkpoint inhibitors (ICI)

Autor:	Svedman, F. Costa, Yang, M., Tuominen, R., Brage, S.E., Höiom, V.
Zdroj:	In Annals of Oncology December 2019 30 Supplement 11:xi8-xi9
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu